An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as a Potential Therapeutic to Attenuate Retinal Angiogenesis.
Saved in:
| Title: | An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as a Potential Therapeutic to Attenuate Retinal Angiogenesis. |
|---|---|
| Authors: | Wang JH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia., Chuang YF; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Chen J; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Singh V; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Lin FL; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Wilson R; Central Science Laboratory, University of Tasmania, Hobart, Tasmania, Australia., Tu L; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Ma C; Molecular Diagnostics Solutions, CSIRO Health and Biosecurity, North Ryde, New South Wales, Australia., Wong RCB; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia., Wang PY; Oujiang Laboratory, Wenzhou, Zhejiang, China., Zhong J; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Hewitt AW; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., van Wijngaarden P; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia., Dusting GJ; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia., Liu GS; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia.; Aier Eye Institute, Changsha, Hunan, China. |
| Source: | Nucleic acid therapeutics [Nucleic Acid Ther] 2022 Aug; Vol. 32 (4), pp. 251-266. Date of Electronic Publication: 2022 Mar 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-3345 (Electronic) Linking ISSN: 21593337 NLM ISO Abbreviation: Nucleic Acid Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
